Dioseptemloside B



Compound IDCDAMM02240
Common nameDioseptemloside B
IUPAC name3-hydroxy-17-(3-hydroxy-6-methylheptan-2-yl)-10,13-dimethyl-16-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-1,2,3,4,7,8,9,11,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-12-one
Molecular formulaC33H54O9

Experimental data

Retention time7.71
Adduct[M+Na]+
Actual mz617.365
Theoretical mz617.366
Error1.81
Ionizaton modePositive
Instrument typeLC-MS/MS-QTOF, spectrum predicted by MS-DIAL v4.9 integrated with MS-FINDER 3.60
Score5.5981

Identifiers and class information

Inchi keySSKCHMMXHKDIIN-OPQVJCIXNA-N
SmilesO=C1CC2C(CC=C3CC(O)CCC32C)C4CC(OC5OC(CO)C(O)C(O)C5O)C(C(C)C(O)CCC(C)C)C14C
SuperclassLipids and lipid-like molecules
ClassSteroids and steroid derivatives

Pharmacokinetic properties

Number of descriptor values(#stars)3
Number of non-conjugated amine groups (#amine)0
Number of amidine and guanidine groups (#amidine)0
Number of carboxylic acid groups (#acid)0
Number of non-conjugated amide groups (#amide)0
Number of rotatable bonds (#rotor)14
Number of reactive functional groups (#rtvFG)1
Predicted central nervous system activity (CNS)-2
Molecular weight (mol_MW)594.784
Computed dipole moment(dipole)3.507
Total solvent accessible surface area (SASA)909.549
Hydrophobic component of SASA (FOSA)652.155
Hydrophilic component of SASA (FISA)230.652
Pie component of the SASA (PISA)26.742
Weakly polar component of the SASA (WPSA)0
Total solvent accesible volume (volume)1807.6
Number of hydrogen bond donors (donorHB)6
Number of hydrogen bond acceptors (accptHB)15.6
Free energy of solvation of dipole (dip^2/V)0.0068032
Index of cohesive interaction in solids (ACxDN^.5/SA)0.0420121
Globularity descriptor (glob)0.788994
Predicted polarizability in cubic angstroms (QPpolrz)57.452
Predicted hexadecane/gas partition coefficient (QPlogPC16)18.109
Predicted octanol/gas partition coefficient (QPlogPoct)36.446
Predicted water/gas partition coefficient (QPlogPw)24.724
Predicted octanol/water partition coefficient (QPlogPo/w)1.99
Predicted aqueous solubility (QPlogS)-4.796
Conformation-independent predicted aqueous solubility (CIQPlogS)-4.956
Predicted IC50 value for blockage of HERG K+ channels (QPlogHERG)-5.074
Predicted apparent Caco-2 cell permeability in nm/sec (QPPCaco)64.362
Predicted brain/blood partition coefficient (QPlogBB)-2.75
Predicted apparent MDCK cell permeability in nm/sec (QPPMDCK)25.505
Predicted skin permeability, log Kp (QPlogKp)-4.332
PM3 calculated ionization potential (IP(ev))9.859
PM3 calculated electron affinity (EA(eV))-0.508
Number of likely metabolic reactions (#metab)9
Prediction of binding to human serum albumin (QPlogKhsa)-0.188
Predicted qualitative human oral absorption (HumanOralAbsorption)2
Predicted human oral absorption on 0 to 100% scale (PercentHumanOralAbsorption)45.051
Solvent-accessible surface area of fluorine atoms (SAFluorine)0
Solvent-accessible surface area of amide oxygen atoms (SAamideO)0
Van der Waals surface area (PSA)162.041
Number of nitrogen and oxygen atoms (#NandO)9
Number of violations of Lipinski’s rule of five (RuleOfFive)2
Number of violations of Jorgensen’s rule of three (RuleOfThree)1

Compound-target network

Cytoscape Graph

Protein targets associated with phytocompound

Uniprot ID Gene name Target name TTD_ID Prediction source
Q15125EBPAnti-estrogen binding site (AEBS)T25317SEA
P08185SERPINA6Corticosteroid binding globulinT88452SEA
Q9UHC9NPC1L1Niemann-Pick C1-like protein 1T33901SEA
Q13133NR1H3LXR-alphaT52297SEA
Q15465SHHSonic hedgehog protein (by homology)T12075SEA
P11413G6PDGlucose-6-phosphate 1-dehydrogenaseT63484SEA
P05093CYP17A1Cytochrome P450 17A1T89041SEA
P60568IL2Interleukin-2T61698SEA
P35398RORANuclear receptor ROR-alphaT43206SEA
P14679TYRTyrosinaseT97035SEA
O15439ABCC4Multidrug resistance protein 4T39919SEA

Target associated diseases

TTD_ID Disease_ID Disease name ICD_11 Uniprot ID Gene names
T25317DI0366Rheumatoid arthritis[ICD-11: FA20]Q15125EBP
T88452DI0037Asthma[ICD-11: CA23]P08185SERPINA6
T88452DI0339Postoperative inflammation[ICD-11: 1A00-CA43]P08185SERPINA6
T88452DI0362Respiratory system disease[ICD-11: CB40-CB7Z]P08185SERPINA6
T33901DI0188Hyper-lipoproteinaemia[ICD-11: 5C80]Q9UHC9NPC1L1
T52297DI0117Depression[ICD-11: 6A70-6A7Z]Q13133NR1H3
T63484DI0086Chronic obstructive pulmonary disease[ICD-11: CA22]P11413G6PD
T89041DI0346Prostate cancer[ICD-11: 2C82]P05093CYP17A1
T61698DI0275Multiple sclerosis[ICD-11: 8A40]P60568IL2
T61698DI0361Renal cell carcinoma[ICD-11: 2C90]P60568IL2
T43206DI0235Liver cancer[ICD-11: 2C12]P35398RORA
T43206DI0417Type 2 diabetes mellitus[ICD-11: 5A11]P35398RORA
T97035DI0007Acquired hypermelanosis[ICD-11: ED60]P14679TYR
T97035DI0008Acquired hypomelanotic disorder[ICD-11: ED63]P14679TYR

Copyright © 2025